Treatment for Youth (Ages 8 to 16 Years Old) With Misophonia (U-HEAR) (U-HEAR)
Unified Protocol to Help Emotions and Promote Auditory Relief (U-HEAR).
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Kelly Kudryk, BA
- Phone Number: 813-586-1630
- Email: kellykudryk@miami.edu
Study Contact Backup
- Name: Jane Mutch, PhD
- Phone Number: 727-767-8230
- Email: rothmanctr@usf.edu
Study Locations
-
-
Florida
-
Coral Gables, Florida, United States, 33124
- Recruiting
- Child and Adolescent Mood and Anxiety Treatment (CAMAT) Program at the University of Miami
-
Contact:
- Ashley Karlovich, BA
- Phone Number: 1 305-284-9852
- Email: anxietylab@psy.miami.edu
-
Saint Petersburg, Florida, United States, 33701
- Recruiting
- University of Florida Rothman Center
-
Contact:
- Kelly Kudryk, BA
- Phone Number: 813-586-1630
- Email: kellykudryk@usf.edu
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The child meets criteria for misophonia
- The child is currently living with their family/guardian(s)
- The child is between 8 and 16 years old
- Parent/legal guardian and child are able to read and speak English without a translator
- Parent/legal guardian is able to attend weekly sessions and all assessments
- If the child is on a psychotropic medication, they will need to be on a stable dose for 4 weeks prior to assessment (2 weeks for stimulant medication)
Exclusion Criteria:
- The child has received prior UP-C/A treatment
- The child is acutely suicidal
- The child has a current diagnosis of psychosis, bipolar disorder, intellectual disability, alcohol/substance dependence, or eating disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: UP-C/A for Misophonia
The Unified Protocols for Transdiagnostic Treatment of Emotional Disorders in Children and Adolescents (UP-C/A) are manualized treatments for treating emotional disorders in youth.
We have modified the UP-C/A to meet the needs for youth with misophonia.
|
Please see arm/group descriptions
|
|
Experimental: Psychoeducation and Relaxation Therapy
Psychoeducation and Relaxation Therapy (PRT) is a treatment that educates the child on misophonia and provides training in relaxation skills and tools for calming panic, anxiety and anger feelings.
|
Please see arm/group descriptions
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improvement in symptoms measured by Clinical Global Impression - Improvement (5 weeks)
Time Frame: 5 weeks
|
Clinical Global Impression-Improvement (CGI-I) is a 7-point clinician rated scale of treatment response anchored by 1 (very much improved) and 7 (very much worse).
For categorical secondary outcomes, response is defined as a CGI-I rating of 1 or 2 (much improved/very much improved), and remission as CGI-S of 1 to 2. CGI-I will be used to measure symptom improvement after 5 weeks of treatment.
|
5 weeks
|
|
Improvement in symptoms measured by Clinical Global Impression - Improvement (10 weeks)
Time Frame: 10 weeks
|
Clinical Global Impression-Improvement (CGI-I) is a 7-point clinician rated scale of treatment response anchored by 1 (very much improved) and 7 (very much worse).
For categorical secondary outcomes, response is defined as a CGI-I rating of 1 or 2 (much improved/very much improved), and remission as CGI-S of 1 to 2. CGI-I will be used to measure symptom improvement after 10 weeks of treatment.
|
10 weeks
|
|
Severity of symptoms measured by Clinical Global Impression - Severity (Baseline)
Time Frame: Baseline
|
Clinical Global Impression-Severity (CGI-S) is a widely used 7-point clinician rating of severity of psychopathology; raters will be instructed to score based on psychopathology and misophonia symptoms.
Severity ratings range from 1 (no illness) to 7 (extremely severe).
Severity will be measured before treatment begins to create a baseline for each participant.
|
Baseline
|
|
Severity of symptoms measured by Clinical Global Impression - Severity (5 weeks)
Time Frame: 5 weeks
|
Clinical Global Impression-Severity (CGI-S) is a widely used 7-point clinician rating of severity of psychopathology; raters will be instructed to score based on psychopathology and misophonia symptoms.
Severity ratings range from 1 (no illness) to 7 (extremely severe).
CGI-S will be used to measure severity after 5 weeks of treatment.
|
5 weeks
|
|
Severity of symptoms measured by Clinical Global Impression - Severity (10 weeks)
Time Frame: 5 weeks
|
Clinical Global Impression-Severity (CGI-S) is a widely used 7-point clinician rating of severity of psychopathology; raters will be instructed to score based on psychopathology and misophonia symptoms.
Severity ratings range from 1 (no illness) to 7 (extremely severe).
CGI-S will be used to measure severity after 10 weeks of treatment.
|
5 weeks
|
|
Overall impairment measured by Child's Global Assessment Scale (Baseline)
Time Frame: Baseline
|
Clinician rated measure of general functioning including impairment to capture functioning/impairment independent of diagnoses.
The child or young person is given a single score between 1 and 100, based on a clinician's assessment of a range of aspects related to a child's psychological and social functioning.
The score will put them in one of ten categories that range from 'extremely impaired' (1-10) to 'doing very well' (91-100.
General functioning of the participant will be measured before treatment begins to create a baseline for each subject.
|
Baseline
|
|
Overall impairment measured by Child's Global Assessment Scale (5 weeks)
Time Frame: 5 weeks
|
Clinician rated measure of general functioning including impairment to capture functioning/impairment independent of diagnoses.
The child or young person is given a single score between 1 and 100, based on a clinician's assessment of a range of aspects related to a child's psychological and social functioning.
The score will put them in one of ten categories that range from 'extremely impaired' (1-10) to 'doing very well' (91-100).
CGAS will be used to measure general functioning after 5 weeks of treatment.
|
5 weeks
|
|
Overall impairment measured by Child's Global Assessment Scale (10 weeks)
Time Frame: 10 weeks
|
Clinician rated measure of general functioning including impairment to capture functioning/impairment independent of diagnoses.
The child or young person is given a single score between 1 and 100, based on a clinician's assessment of a range of aspects related to a child's psychological and social functioning.
The score will put them in one of ten categories that range from 'extremely impaired' (1-10) to 'doing very well' (91-100).
CGAS will be used to measure general functioning after 10 weeks of treatment.
|
10 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Misophonia symptoms as measured by Misophonia Assessment Questionnaire
Time Frame: Baseline
|
Misophonia Assessment Questionnaire (MAQ) is a 21 item, youth self-report, and parent-report questionnaire assessing severity and side effects of the youth's misophonia symptoms and reactions to misophonic sounds.
|
Baseline
|
|
Change in misophonia symptoms as measured by Misophonia Assessment Questionnaire
Time Frame: 5 weeks
|
Misophonia Assessment Questionnaire (MAQ) is a 21 item, youth self-report, and parent-report questionnaire assessing severity and side effects of the youth's misophonia symptoms and reactions to misophonic sounds.
|
5 weeks
|
|
Change in misophonia symptoms as measured by Misophonia Assessment Questionnaire
Time Frame: 10 weeks
|
Misophonia Assessment Questionnaire (MAQ) is a 21 item, youth self-report, and parent-report questionnaire assessing severity and side effects of the youth's misophonia symptoms and reactions to misophonic sounds.
|
10 weeks
|
|
Misophonia symptoms as measured by Misophonia Questionnaire
Time Frame: Baseline
|
The Misophonia Questionnaire is a 17-item questionnaire that assesses the presence of misophonia symptoms, emotions and behaviors associated with misophonic reactions, and symptom severity.
The first two subscales are rated on a scale of 0 (not at all true) to 4 (always true).
These two parts are summed to produce a total score ranging from 0 - 68.
The severity subscale is a single item that asks an individual to provide a rating of their sound sensitivity on a scale from 0 (no sound sensitivities) to 15 (very severe sound sensitivities).
The youth self-report (for those 10 and older) and parent report will serve as both a measure of symptoms of misophonia and allow for calculation of severity score.
|
Baseline
|
|
Change in misophonia symptoms as measured by Misophonia Questionnaire
Time Frame: 5 weeks
|
The Misophonia Questionnaire is a 17-item questionnaire that assesses the presence of misophonia symptoms, emotions and behaviors associated with misophonic reactions, and symptom severity.
The first two subscales are rated on a scale of 0 (not at all true) to 4 (always true).
These two parts are summed to produce a total score ranging from 0 - 68.
The severity subscale is a single item that asks an individual to provide a rating of their sound sensitivity on a scale from 0 (no sound sensitivities) to 15 (very severe sound sensitivities).
The youth self-report (for those 10 and older) and parent report will serve as both a measure of symptoms of misophonia and allow for calculation of severity score.
|
5 weeks
|
|
Change in misophonia symptoms as measured by Misophonia Questionnaire
Time Frame: 10 weeks
|
The Misophonia Questionnaire is a 17-item questionnaire that assesses the presence of misophonia symptoms, emotions and behaviors associated with misophonic reactions, and symptom severity.
The first two subscales are rated on a scale of 0 (not at all true) to 4 (always true).
These two parts are summed to produce a total score ranging from 0 - 68.
The severity subscale is a single item that asks an individual to provide a rating of their sound sensitivity on a scale from 0 (no sound sensitivities) to 15 (very severe sound sensitivities).
The youth self-report (for those 10 and older) and parent report will serve as both a measure of symptoms of misophonia and allow for calculation of severity score.
|
10 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Adam Lewin, PhD, University of South Florida
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- Pro#00042498
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.